Active substance · J07AP03
Salmonella typhi vi capsular polysaccharide vaccine
Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ07
- Pharmacological subgroupJ07A
- Chemical subgroupJ07AP
- Chemical substanceJ07AP03Typhoid, purified polysaccharide antigen
Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 2 medicines · Historical list
All medicines with Salmonella typhi vi capsular polysaccharide vaccine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
3 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Typherix | Canada | 25 MCG / 0.5 ML | Liquid | Cancelled | Glaxosmithkline INC |
| VivaximCombination | Canada | 160 UNIT / 0.5 ML + 25 MCG / 0.5 ML | Solution, Suspension | Cancelled | Sanofi Vaccines Canada LTD. |
| Typhim Vi | Canada | 25 MCG / 0.5 ML | Solution | Marketed | Sanofi Vaccines Canada LTD. |



